Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.
Fouad TM, Ueno NT, Yu RK, Ensor JE, Alvarez RH, Krishnamurthy S, Lucci A, Reuben JM, Yang W, Willey JS, Valero V, Bondy ML, Cristofinalli M, Shete S, Woodward WA, El-Zein R. Fouad TM, et al. Among authors: valero v. PLoS One. 2018 Sep 24;13(9):e0204372. doi: 10.1371/journal.pone.0204372. eCollection 2018. PLoS One. 2018. PMID: 30248155 Free PMC article.
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.
Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D, Valero V, Arun B, Ibrahim N, Rivera E, Royce M, Cleeland CS, Hortobagyi GN. Pusztai L, et al. Among authors: valero v. Cytokine. 2004 Feb 7;25(3):94-102. doi: 10.1016/j.cyto.2003.10.004. Cytokine. 2004. PMID: 14698135 Clinical Trial.
p53 expression as a prognostic marker in inflammatory breast cancer.
Gonzalez-Angulo AM, Sneige N, Buzdar AU, Valero V, Kau SW, Broglio K, Yamamura Y, Hortobagyi GN, Cristofanilli M. Gonzalez-Angulo AM, et al. Among authors: valero v. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6215-21. doi: 10.1158/1078-0432.CCR-04-0202. Clin Cancer Res. 2004. PMID: 15448010
Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.
Hanrahan EO, Broglio KR, Buzdar AU, Theriault RL, Valero V, Cristofanilli M, Yin G, Kau SW, Hortobagyi GN, Rivera E. Hanrahan EO, et al. Among authors: valero v. Cancer. 2005 Sep 15;104(6):1158-71. doi: 10.1002/cncr.21305. Cancer. 2005. PMID: 16047352 Free article.
Squamous cell carcinoma of the breast.
Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, Valero V, Hortobagyi GN. Hennessy BT, et al. Among authors: valero v. J Clin Oncol. 2005 Nov 1;23(31):7827-35. doi: 10.1200/JCO.2004.00.9589. J Clin Oncol. 2005. PMID: 16258085
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach.
Cristofanilli M, Krishnamurthy S, Guerra L, Broglio K, Arun B, Booser DJ, Menander K, Van Wart Hood J, Valero V, Hortobagyi GN. Cristofanilli M, et al. Among authors: valero v. Cancer. 2006 Sep 1;107(5):935-44. doi: 10.1002/cncr.22080. Cancer. 2006. PMID: 16874816 Free article. Clinical Trial.
486 results